» Articles » PMID: 32389804

Recombinant BRICHOS Chaperone Domains Delivered to Mouse Brain Parenchyma by Focused Ultrasound and Microbubbles Are Internalized by Hippocampal and Cortical Neurons

Overview
Date 2020 May 12
PMID 32389804
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The BRICHOS domain is found in human precursor proteins associated with cancer, dementia (Bri2) and amyloid lung disease (proSP-C). Recombinant human (rh) proSP-C and Bri2 BRICHOS domains delay amyloid-β peptide (Aβ) fibril formation and reduce associated toxicity in vitro and their overexpression reduces Aβ neurotoxicity in animal models of Alzheimer's disease. After intravenous administration in wild-type mice, rh Bri2, but not proSP-C, BRICHOS was detected in the brain parenchyma, suggesting that Bri2 BRICHOS selectively bypasses the blood-brain barrier (BBB). Here, our objective was to increase the brain delivery of rh proSP-C (trimer of 18 kDa subunits) and Bri2 BRICHOS (monomer to oligomer of 15 kDa subunits) using focused ultrasound combined with intravenous microbubbles (FUS + MB), which enables targeted and transient opening of the BBB. FUS + MB was targeted to one hemisphere of wild type mice and BBB opening in the hippocampal region was confirmed by magnetic resonance imaging. Two hours after FUS + MB brain histology showed no signs of tissue damage and immunohistochemistry showed abundant delivery to the brain parenchyma in 13 out of 16 cases given 10 mg/kg of proSP-C or Bri2 BRICHOS domains. The Bri2, but not proSP-C BRICHOS domain was detected also in the non-targeted hemisphere. ProSP-C and Bri2 BRICHOS domains were taken up by a subset of neurons in the hippocampus and cortex, and were detected to a minor extent in early endosomes. These results indicate that rh Bri2, but not proSP-C, BRICHOS, can be efficiently delivered into the mouse brain parenchyma and that both BRICHOS domains can be internalized by cell-specific mechanisms.

Citing Articles

Intravenous chaperone treatment of late-stage Alzheimer´s disease (AD) mouse model affects amyloid plaque load, reactive gliosis and AD-related genes.

Zhang R, Ohshima M, Brodin D, Wang Y, Morance A, Schultzberg M Transl Psychiatry. 2024; 14(1):453.

PMID: 39448576 PMC: 11502864. DOI: 10.1038/s41398-024-03161-x.


A comprehensive review of advanced focused ultrasound (FUS) microbubbles-mediated treatment of Alzheimer's disease.

Rouhi N, Chakeri Z, Ghorbani Nejad B, Rahimzadegan M, Khezri M, Kamali H Heliyon. 2024; 10(18):e37533.

PMID: 39309880 PMC: 11416559. DOI: 10.1016/j.heliyon.2024.e37533.


Specific inhibition of α-synuclein oligomer generation and toxicity by the chaperone domain Bri2 BRICHOS.

Adam L, Kumar R, Arroyo-Garcia L, Molenkamp W, Nowak J, Klute H Protein Sci. 2024; 33(8):e5091.

PMID: 38980078 PMC: 11232276. DOI: 10.1002/pro.5091.


Development of an In Vitro Model to Study Mechanisms of Ultrasound-Targeted Microbubble Cavitation-Mediated Blood-Brain Barrier Opening.

Conway G, Paranjape A, Chen X, Villanueva F Ultrasound Med Biol. 2023; 50(3):425-433.

PMID: 38158246 PMC: 10843834. DOI: 10.1016/j.ultrasmedbio.2023.12.005.


Amyloid inhibition by molecular chaperones can be translated to Alzheimer's pathology .

Abelein A, Johansson J RSC Med Chem. 2023; 14(5):848-857.

PMID: 37252101 PMC: 10211315. DOI: 10.1039/d3md00040k.